VIR Q1 2020 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+33535.3% YoY

Gross Profit

-$52M-911.1% margin

Operating Income

-$72M-1257.6% margin

Net Income

-$77M-1350.8% margin

EPS (Diluted)

$-0.71

QoQ Revenue Growth

+483.5%

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$50M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$477M

Total Liabilities

$97M

Stockholders' Equity

$380M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$17,000	+33535.3%
Gross Profit	-$52M	-$26M	-101.5%
Operating Income	-$72M	-$31M	-133.7%
Net Income	-$77M	-$29M	-169.4%

Revenue Segments

Grant

$200,000100%